Digoxin Enhances the Anticancer Effect on Non-Small Cell Lung Cancer While Reducing the Cardiotoxicity of Adriamycin

Digoxin is widely used to treat heart failure. Epidemiological studies suggested it might be used as an anticancer drug or sensitizing agent for cancer therapy. Adriamycin is a well-known anticancer drug, but often causes cardiotoxicity which limits its use. We recently investigated the anticancer e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yingying, Ma, Qian, Zhang, Shaolu, Liu, Hongyan, Zhao, Baoquan, Du, Bo, Wang, Wei, Lin, Peng, Zhang, Zhe, Zhong, Yuxu, Kong, Dexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059749/
https://www.ncbi.nlm.nih.gov/pubmed/32180730
http://dx.doi.org/10.3389/fphar.2020.00186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059749/
https://www.ncbi.nlm.nih.gov/pubmed/32180730
http://dx.doi.org/10.3389/fphar.2020.00186

Ejemplares similares